Company intelligence / Profile preview

Mango

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Mango develops and commercializes the M6, a fully automated microbial detection system that delivers sterility and bioburden test results in hours instead of days for biopharma and other regulated manufacturing quality-control labs.[4][2] It is a QC-enabling technology rather than a therapeutic developer and therefore has no clinical trial programs.

Industry: Pathology

Beyond the preview

Go deeper on Mango.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mango.

Explore the full profile